Entering text into the input field will update the search result below

GSK, Sanofi stand by Zantac safety, try to calm investors

Aug. 12, 2022 5:39 AM ETPfizer Inc. (PFE) Stock, SNY Stock, GSK StockHLNBy: Ravikash Bakolia, SA News Editor9 Comments

Group business people and lawyers meeting together. Consulting in regard to the various contracts at meeting.

AmnajKhetsamtip/iStock via Getty Images

GSK (NYSE:GSK) and Sanofi (NASDAQ:SNY) defended their stance on heartburn drug Zantac (ranitidine) noting that since 2019 the researches conducted by different agencies and the companies have shown that there was no evidence

Recommended For You

Related Stocks

SymbolLast Price% Chg
GSK
--
PFE
--
SNY
--